Connect with us

Hi, what are you looking for?

Friday, Jul 24, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "biotech"

CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech

CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech

Medical and Pharmaceutical

CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech

The pivotal agreement is valued at up to US$100 million

Rowan Dunne2 days ago

Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover

Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover

Psychedelics

Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover

AtaiBeckley stock rose more than 55% in after-hours trading Wednesday

Rowan DunneJuly 16, 2026

Definium Therapeutics soars on Phase 3 trial win with LSD depression drug

Definium Therapeutics soars on Phase 3 trial win with LSD depression drug

Psychedelics

Definium Therapeutics soars on Phase 3 trial win with LSD depression drug

The rally follows year-to-date gains of nearly 175%

Rowan DunneJune 24, 2026

Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug

Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug

Psychedelics

Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug

The biotech is preparing for in-human trials with 'PSIL-006' next year

Rowan DunneMay 29, 2026

CNS Pharma sees 250% spike from oversubscribed private placement

CNS Pharma sees 250% spike from oversubscribed private placement

Medical and Pharmaceutical

CNS Pharma sees 250% spike from oversubscribed private placement

The oncology and biotech firm has secured approximately US$22.5 million

Rowan DunneMay 5, 2026

Optimi Health launches ibogaine initiative in response to Trump's executive order

Optimi Health launches ibogaine initiative in response to Trump's executive order

Psychedelics

Optimi Health launches ibogaine initiative in response to Trump’s executive order

Psychedelic stocks surged after the president gave his signature

Rowan DunneApril 21, 2026

Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug

Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug

Medical and Pharmaceutical

Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug

The authorization could help facilitate significant revenue growth

Rowan DunneApril 12, 2026

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

Medical and Pharmaceutical

bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction

Shares rose by 73% during the session with no immediate catalyst

Rowan DunneMarch 23, 2026

Immutep completely tanks after discontinuing lung cancer drug trial

Immutep completely tanks after discontinuing lung cancer drug trial

Medical and Pharmaceutical

Immutep completely tanks after discontinuing lung cancer drug trial

Shares dropped by 88% on Friday the 13th, leaving investors shook

Rowan DunneMarch 16, 2026

Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics

Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics

Medical and Pharmaceutical

Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics

Shares surged by 16% after the deal was announced

Rowan DunneMarch 2, 2026

More Posts

Page 1 of 412 3 4